Clinical trial
Increasing HAART-Induced Immune Restoration With Cyclosporine
NCT00031070
Study timeline
Registry last updated2015-03-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV Infectionsunresolved
Interventions
CyclosporineDRUG · verified · RxNorm: cyclosporine
Hepatitis A Vaccine (Inactivated)BIOLOGICAL
EfavirenzDRUG · verified · RxNorm: efavirenz
Rabies VaccineBIOLOGICAL
Sponsors & collaborators
Mapped research locations
ChicagoIllinois, United States2DallasTexas, United States2ClevelandOhio, United States2Chapel HillNorth Carolina, United States2PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1MiamiFlorida, United States1IndianapolisIndiana, United States1MinneapolisMinnesota, United States1SacramentoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00031070 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.